Data / Drug companies / Pamabrom
Pamabrom: 7 companies and 7 products in the FDA NDC directory
Pamabrom is listed in the FDA National Drug Code Directory by 7 companies, with 7 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule, liquid filled; tablet, film coated; tablet, and the newest product started marketing on April 7, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 7
- Products
- 7
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 1
- Routes
- Oral
- Brand names
- Right Remedies Maximum Strength Diuretic, Menstrual Bloat Relief, Pamprin Bloat, Midol Bloat Relief, Diurex Max
- openFDA record search
- api.fda.gov
Companies that list pamabrom
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bayer HealthCare LLC. | 1 | tablet | Over the counter monograph drugs | April 28, 2021 |
| Focus Consumer Healthcare, LLC | 1 | tablet, film coated | Over the counter monograph drugs | December 31, 2025 |
| Kobayashi Healthcare International, Inc. | 1 | tablet, film coated | Over the counter monograph drugs | December 20, 1995 |
| Softgel Healthcare Pvt Ltd | 1 | capsule, liquid filled | Over the counter monograph drugs | May 21, 2024 |
| Strive Pharmaceuticals Inc. | 1 | capsule, liquid filled | Over the counter monograph drugs | May 7, 2025 |
| Walgreen Company | 1 | capsule, liquid filled | Other unapproved drugs | November 24, 2020 |
| Walmart Inc. | 1 | tablet, film coated | Over the counter monograph drugs | April 7, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule, liquid filled | 3 | 42.9% |
| Tablet, film coated | 3 | 42.9% |
| Tablet | 1 | 14.3% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 6 | 85.7% |
| Other unapproved drugs | 1 | 14.3% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.